[HTML][HTML] GSK-3: a key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput

CA Zarate Jr, R Machado-Vieira - Bipolar disorders, 2016 - ncbi.nlm.nih.gov
In the past decade, studies that provide insights into the mechanisms of action underlying
ketamine's rapid antidepressant effects have been key to identifying relevant targets for …

[引用][C] GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput

CA Zarate Jr, R Machado-Vieira - Bipolar disorders, 2016 - pubmed.ncbi.nlm.nih.gov
GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced
AMPA to NMDA throughput GSK-3: A key regulatory target for ketamine's rapid antidepressant …

[引用][C] GSK‐3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput

CA Zarate Jr, R Machado‐Vieira - Bipolar Disorders, 2016 - Wiley Online Library
In the past decade, studies that provided insights into the mechanisms of action underlying
ketamine's rapid antidepressant effects have been key to identifying relevant targets for …

[引用][C] GSK‐3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput

CA Zarate, R Machado‐Vieira - Bipolar Disorders, 2017 - infona.pl
GSK‐3: A key regulatory target for ketamine's rapid antidepressant effects mediated by
enhanced AMPA to NMDA throughput × Close The Infona portal uses cookies, ie strings of text …

GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput.

CA Zarate Jr, R Machado-Vieira - Bipolar Disorders, 2016 - europepmc.org
In the past decade, studies that provide insights into the mechanisms of action underlying
ketamine's rapid antidepressant effects have been key to identifying relevant targets for …